Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-039637

Chief Financial Officer sold 20,000 shares at an average $36.33 ($726,519)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-08 Exercise or conversion : show line 1 in the form +10,000 $6.55 $65,500 31,604 D
2021-06-08 Sale : show line 2 in the form −8,401 $36.90 $309,997 23,203 D
2021-06-08 Sale : show line 3 in the form −1,599 $37.85 $60,522 21,604 D
2021-06-09 Exercise or conversion : show line 4 in the form +10,000 $6.55 $65,500 31,604 D
2021-06-09 Sale : show line 5 in the form −10,000 $35.60 $356,000 21,604 D
Open-market sales · 20,000 sh · avg $36.33 · $726,519

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-06-08 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −10,000 120,000 D
2021-06-09 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −10,000 110,000 D
Loading xslF345X03/doc4.xml…